ArticleTransplant infectious disease : an official journal of the Transplantation Society2021

Development and longevity of antibodies against SARS-CoV-2 in kidney transplant recipients after symptomatic COVID-19.

Divya Bajpai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.